| Literature DB >> 33518163 |
Gerard E Mullin1, Berkeley N Limketkai2, Alyssa M Parian3.
Abstract
Dietary supplements have increasingly gained popularity over the years not only to replete micronutrient deficiencies but for their use in treatment of disease. The popularity of dietary supplements for inflammatory bowel diseases (IBD) arises from their perceived ease of use, potential disease-modifying benefits, and perceived safety. Overall, randomized controlled trials have not consistently shown a benefit of fish oil for the maintenance of remission with Crohn's disease. The inconsistency of these findings highlights the need for more studies that are powered to clarify the context in which omega-3 fatty acids might have a role in the treatment algorithm of IBD.Entities:
Keywords: Dietary supplements; Docosahexaenoic acid (DHA); Fish oil; Inflammatory bowel disease, eicosapentaenoic acid (EPA); Omega-3 fatty acids; α-Linolenic acid (ALA)
Year: 2021 PMID: 33518163 DOI: 10.1016/j.gtc.2020.10.010
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806